AAAAAA
Results: 1-25/75
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP-93/, Bone marrow transplantation, 21, 1998, pp. 585-585
Authors:
SIMON D
HAIOUN C
GAULARD P
SALLES G
TILLY H
BOSLY A
DIEBOLD J
GISSELBRECHT C
Citation: D. Simon et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PTCL, Bone marrow transplantation, 21, 1998, pp. 593-593
Authors:
JACQUY C
LAMBERT F
VANDAELE S
BOSLY A
FERRANT A
MARTIAT P
Citation: C. Jacquy et al., PERIPHERAL-BLOOD STEM-CELL CONTAMINATION IN MANTLE CELL NON-HODGKIN-LYMPHOMA - THE CASE FOR PURGING, Bone marrow transplantation, 21, 1998, pp. 618-618
Authors:
SIMON D
GISSELBRECHT C
SEBBAN C
REYES F
BOSLY A
GABARRE J
MOREL P
BOULAT O
LEPAGE E
Citation: D. Simon et al., SYSTEM OF THERAPEUTIC DECISION-MAKING FOR G-CSF PRESCRIPTION IN AGGRESSIVE NON-HODGKIN LYMPHOMAS, British Journal of Haematology, 102(1), 1998, pp. 90-90
Authors:
CEDRONE M
MANCINI W
NANNI M
DECUIA MR
PETIT MC
BOSLY A
MICHAUX JL
SELLESLAG D
BRAMA M
ANGELOZZI AL
MECUCCI C
ALIMENA G
HAGEMEIJER A
Citation: M. Cedrone et al., USE OF DUAL-COLOR INTERPHASE-FISH TECHNIQUE AT DIAGNOSIS, AT RELAPSE AND DURING THE FOLLOW-UP OF INV(16) AML PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 98-98
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH-RP-93/, British Journal of Haematology, 102(1), 1998, pp. 148-148
Authors:
GISSELBRECHT C
GAULARD P
LEPAGE E
COIFFIER B
BRIERE J
HAIOUN C
CAZALSHATEM D
BOSLY A
XERRI L
TILLY H
BERGER F
BOUHABDALLAH R
DIEBOLD J
Citation: C. Gisselbrecht et al., PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Blood, 92(1), 1998, pp. 76-82
Authors:
DHONDT L
ANDRE M
GUILLAUME T
FEYENS AM
HUMBLET Y
DOYEN C
BOSLY A
DROMELET A
CHATELAIN B
SYMANN M
Citation: L. Dhondt et al., QUANTIFICATION OF CD34(-BLOOD PREDICTS THE YIELD OF THE LEUKAPHERESISPRODUCT AND CAN REPLACE PROGENITOR ASSAYS() CELLS MOBILIZED INTO THE PERIPHERAL), Cytokines cellular & molecular therapy, 3(1), 1997, pp. 21-26
Authors:
GISSELBRECHT C
HAIOUN C
LEPAGE E
BASTION Y
TILLY H
BOSLY A
DUPRIEZ B
MARIT G
HERBRECHT R
DECONINCK E
MAROLLEAU JP
YVER A
DABOUZHARROUCHE F
COIFFIER B
REYES F
Citation: C. Gisselbrecht et al., PLACEBO-CONTROLLED PHASE-III STUDY OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA - FACTORS INFLUENCING CHEMOTHERAPY ADMINISTRATION, Leukemia & lymphoma, 25(3-4), 1997, pp. 289-300
Authors:
HAIOUN C
LEPAGE E
GISSELBRECHT C
BASTION Y
COIFFIER B
BRICE P
BOSLY A
DUPRIEZ B
NOUVEL C
TILLY H
LEDERLIN P
BIRON P
BRIERE J
GAULARD P
REYES F
Citation: C. Haioun et al., BENEFIT OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION OVER SEQUENTIAL CHEMOTHERAPY IN POOR-RISK AGGRESSIVE NON-HODGKINS-LYMPHOMA - UPDATED RESULTS OF THE PROSPECTIVE-STUDY LNH87-2, Journal of clinical oncology, 15(3), 1997, pp. 1131-1137
Authors:
BOSLY A
COIFFIER B
Citation: A. Bosly et B. Coiffier, RECENT DATA ON THE EPIDEMIOLOGY OF NON-HO DGKINS-LYMPHOMA, Pathologie et biologie, 45(6), 1997, pp. 449-452
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
COIFFIER B
Citation: A. Bosly et al., LATE INTENSIFICATION IS SUPERIOR TO EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP93/, Experimental hematology, 25(8), 1997, pp. 16-16
Authors:
HAIOUN C
LEPAGE E
SALLES G
MOREL P
GABARRE J
LEDERLIN P
TILLY H
BOSLY A
GAULARD P
COIFFIER B
GISSELBRECHT C
REYES F
Citation: C. Haioun et al., BONE-MARROW INVOLVEMENT AND LOW SERUM-ALBUMIN LEVEL ARE USEFUL TO BETTER PREDICT SURVIVAL OF POOR-RISK PATIENTS WITH AGGRESSIVE LYMPHOMA ASDEFINED BY THE AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX (AA-IPI), Blood, 90(10), 1997, pp. 3899-3899
Authors:
SIMON D
GISSELBRECHT C
SEBBAN C
REYES F
BOSLY A
GABARRE J
MOREL P
BOULAT O
LEPAGE E
Citation: D. Simon et al., IDENTIFICATION OF INFECTION PROGNOSTIC FACTORS IN AGGRESSIVE NON-HODGKIN LYMPHOMAS TREATED WITH MYELOSUPPRESSIVE CYCLES OF CHEMOTHERAPY, Blood, 90(10), 1997, pp. 3956-3956
Authors:
JACQUY C
LAMBERT F
VANDAELE S
BOSLY A
FERRANT A
MARTIAT P
Citation: C. Jacquy et al., PERIPHERAL-BLOOD STEM-CELL CONTAMINATION IN MANTLE CELL NON-HODGKIN-LYMPHOMA - THE CASE FOR PURGING, Blood, 90(10), 1997, pp. 4333-4333
Authors:
BELANGER C
SOLALCELIGNY P
NEIDHARDT EM
PRICE P
BROUSSE N
CASPARD H
HAIOUN C
BOSLY A
TILLY H
BORDESSOULE D
SEBBAN C
HARROUSSEAU JL
MOREL P
LEPORRIER M
Citation: C. Belanger et al., FLUDARABINE MONOPHOSPHATE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA - UPDATED ANALYSIS OF AND SALVAGE TREATMENT RESULTS FROM THE GROUPE-DETUDE-DES-LYMPHOMES-DE-DADULTE (GELA) TRIAL, Blood, 90(10), 1997, pp. 1534-1534
Authors:
DELANNOY A
LOUWAGIE AC
KLUINNELEMANS JC
VANDENBURGH JF
BOOGAERTS MA
BOSLY A
MICHAUX JL
ZACHEE P
HAGEMEIJER A
VANDENBERGHE H
Citation: A. Delannoy et al., A RANDOMIZED STUDY ON HYDROXYUREA ALONE VERSUS HYDROXYUREA COMBINED WITH LOW-DOSE INTERFERON-ALPHA-2B FOR CHRONIC MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 2304-2304
Authors:
MOREL P
MUNCK JN
COIFFIER B
GISSELBRECHT C
LEDERLIN P
LAVAUD A
BOSLY A
TILLY H
QUESNEL B
THYSS A
SCHLAIFER D
BRIERE J
REYES F
Citation: P. Morel et al., ECVB - A NEW HIGH-DOSE CHOP REGIMEN FOLLOWED BY AN INTENSIVE CONSOLIDATION IN PATIENTS (PTS) AGED LESS-THAN-OR-EQUAL-TO-60 YEARS WITH AGGRESSIVE LYMPHOMA (NHL) PRESENTING WITH ONLY ONE ADVERSE PROGNOSTIC FACTOR OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) - AN INTERIM ANALYSIS OFTHE LNH93-2 PROTOCOL ON 433 PTS, Blood, 90(10), 1997, pp. 2610-2610
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP-93/, Blood, 90(10), 1997, pp. 2639-2639
Authors:
REYES F
LEPAGE E
MOREL P
LEDERLIN P
COIFFIER B
TILLY H
BOSLY A
GABARRE J
BRIERE J
FILLET G
MOLINA T
GISSELBRECHT C
Citation: F. Reyes et al., FAILURE OF FIRST-LINE INDUCTIVE HIGH-DOSE CHEMOTHERAPY (HDC) IN POOR-RISK PATIENTS (PTS) WITH AGGRESSIVE LYMPHOMA - UPDATED RESULTS OF THE RANDOMIZED LNH93-3 STUDY, Blood, 90(10), 1997, pp. 2640-2640
Authors:
DHONDT L
CHATELAIN C
DOYEN C
OSSELAER JC
FERRANT A
BOSLY A
Citation: L. Dhondt et al., TRANSIENT COMPLETE REMISSION OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION INDUCED BY DONOR LEUKOCYTE TRANSFUSIONS, HEM CELL TH, 38(4), 1996, pp. 353-354
Authors:
CORNELIS F
MONTFORT L
OSSELAER JC
SONET A
DOYEN C
CHATELAIN C
CHATELAIN B
BOSLY A
Citation: F. Cornelis et al., ACUTE-LEUKEMIA IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - CASE-REPORT AND REVIEW OF THE LITERATURE, HEM CELL TH, 38(3), 1996, pp. 285-288
Authors:
MAEREVOET M
VANDENNESTE E
DELANNOY A
FERRANT A
MARTIAT P
BOSLY A
FAUCHET M
MICHAUX JL
Citation: M. Maerevoet et al., LIMITED ACTIVITY OF MINI-DOSE INTERFERON ALPHA-2A IN THE TREATMENT OFMYELODYSPLASTIC SYNDROME, Leukemia & lymphoma, 21(5-6), 1996, pp. 519-520
Authors:
VELLOSO ERP
MECUCCI C
MICHAUX L
VANORSHOVEN A
STUL M
BOOGAERTS M
BOSLY A
CASSIMAN JJ
VANDENBERGHE H
Citation: Erp. Velloso et al., TRANSLOCATION T(8-16)(P11-P13) IN ACUTE NONLYMPHOCYTIC LEUKEMIA - REPORT ON 2 NEW CASES AND REVIEW OF THE LITERATURE, Leukemia & lymphoma, 21(1-2), 1996, pp. 137-142
Authors:
VANDENNESTE E
DELANNOY A
VANDERCAM B
BOSLY A
FERRANT A
MINEUR P
MONTIFORT L
MARTIAT P
STRAETMANS N
FILLEUL B
MICHAUX JL
Citation: E. Vandenneste et al., INFECTIOUS COMPLICATIONS AFTER 2-CHLORODEOXYADENOSINE THERAPY, European journal of haematology, 56(4), 1996, pp. 235-240